The alleviation of lipotoxicity, glucotoxicity, inhibition of mitochondrial apoptosis, and reduction in liver fat content that have been related to the benefits of GLP-1 RAs in NAFLD might also be important [85]. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.